Perspective Therapeutics Inc.

CATX | AMEX

$2.89

-$0.08 (-2.69%)

Sep 22, 2026, 11:22 AM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Jun 29, 2022	FY 2020 Jun 29, 2021
Net Income	-103.12M	-79.28M	-46.51M	-10.76M	-7.27M	-3.39M
Depreciation & Amortization	3.25M	2.31M	986K	324K	248K	149K
Stock-Based Compensation	8.97M	5.39M	3.74M	807K	1.09M	386K
Other Working Capital	1.57M	29.74M	790K	-28K	182K	100K
Other Non-Cash Items	7.53M	23.58M	4.6M	968K	77K	82K
Deferred Income Tax	-793K	-2.1M	-2.65M	n/a	n/a	n/a
Change in Working Capital	1.68M	31.81M	2.92M	-1.74M	-1.85M	-67K
Operating Cash Flow	-82.48M	-18.29M	-36.91M	-10.4M	-7.71M	-2.84M
Capital Expenditures	-12.75M	-54.41M	-1.07M	-282K	-266K	-381K
Cash Acquisitions	n/a	n/a	2.7M	n/a	n/a	n/a
Purchase of Investments	-119.84M	-243.51M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	173.95M	78.73M	22.76M	n/a	n/a	n/a
Other Investing Acitivies	-135K	263K	-18K	-28.71M	-18K	-29K
Investing Cash Flow	41.23M	-218.93M	24.37M	-28.99M	-284K	-410K
Debt Repayment	-52K	-48K	-68K	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	-9K
Other Financial Acitivies	n/a	n/a	-65K	28K	n/a	n/a
Financial Cash Flow	10.31M	289.39M	785K	28K	56K	64.68M
Net Cash Flow	-30.95M	52.16M	-11.76M	-7.94M	-7.94M	61.44M
Free Cash Flow	-95.23M	-72.71M	-37.99M	-10.68M	-7.98M	-3.22M
Adj. Free Cash Flow	-104.2M	-78.1M	-41.72M	-11.49M	-9.06M	-3.6M
Maintenance CapEx	-12.75M	-54.38M	-1.07M	-282K	-90.27K	-297.21K
Growth CapEx	n/a	-32.45K	n/a	n/a	-175.74K	-83.79K
Owner Earnings	-95.23M	-72.68M	-37.99M	-10.68M	-7.8M	-3.13M